Literature DB >> 27362875

Resistance to levothyroxine in a bariatric surgery patient: an indication for liquid formulation?

Christophe Hommel1,2, Etienne Delgrange1.   

Abstract

We report the case of a 49-year-old female patient with hypothyroidism who underwent bariatric surgery and developed severe hypothyroidism despite high doses of oral levothyroxine (L-T4) tablets. Initially, a high-dose L-T4 tablets absorption test was performed to exclude pseudo-malabsorption. In view of a modest increase in serum T4 levels, L-T4 liquid formulation absorption test was performed, and showed faster and more efficient absorption of thyroid hormones. We discuss the issue of distinguishing malabsorption from pseudo-malabsorption, review the literature concerning the benefits of liquid L-T4 in cases of impaired absorption such as bariatric surgery and consider the socio-economic implications of different liquid formulations.

Entities:  

Keywords:  BMI, Body mass index; Bariatric surgery; L-T4, Levothyroxine; Levothyroxine; Liquid formulation; Malabsorption; PPI, Proton pump inhibitors; Pseudo-malabsorption

Mesh:

Substances:

Year:  2016        PMID: 27362875     DOI: 10.1080/17843286.2016.1196861

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  4 in total

Review 1.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

2.  Major imbalance of thyroid function after laparoscopic sleeve gastrectomy.

Authors:  Laurent Brutus; Armelle Poupard; Clément Le Glatin
Journal:  BMJ Case Rep       Date:  2019-08-10

3.  Levothyroxine Therapy: Changes of TSH Levels by Switching Patients from Tablet to Liquid Formulation. A Systematic Review and Meta-Analysis.

Authors:  Camilla Virili; Luca Giovanella; Poupak Fallahi; Alessandro Antonelli; Maria Giulia Santaguida; Marco Centanni; Pierpaolo Trimboli
Journal:  Front Endocrinol (Lausanne)       Date:  2018-01-26       Impact factor: 5.555

Review 4.  Levothyroxine Therapy in Gastric Malabsorptive Disorders.

Authors:  Camilla Virili; Nunzia Brusca; Silvia Capriello; Marco Centanni
Journal:  Front Endocrinol (Lausanne)       Date:  2021-01-28       Impact factor: 5.555

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.